CLINICAL_TRIALS
trial_result
· 2015-05-21
Clinical Trial Update: Comparison of Insulin Mix25 Versus Mix50 [Phase 4]
Summary
A Phase 4 trial comparing two insulin premixes, Mix25 and Mix50, in Type 2 diabetes mellitus patients; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2015-05-21